C Le Pen

Summary

Affiliation: CLP Sant
Country: France

Publications

  1. ncbi request reprint The burden cost of French patients suffering from irritable bowel syndrome
    C Le Pen
    Université Paris Dauphine and CLP Santé, Paris, France
    Scand J Gastroenterol 39:336-43. 2004
  2. ncbi request reprint Choice of GPIIb/IIIa antagonist in percutaneous coronary intervention: how should economic criteria be factored in?
    Claude Le Pen
    CLP Santé, 9 11 rue du Mont Aigoual, 75015 Paris, France
    Pharm World Sci 27:83-91. 2005
  3. ncbi request reprint [A cost-effectiveness analysis of changes in therapeutic strategies in the treatment of HIV since 1996]
    C Le Pen
    Université de Paris Dauphine, France
    Therapie 57:27-33. 2002
  4. ncbi request reprint The drug budget silo mentality: the French case
    Claude Le Pen
    University of Paris Dauphine, Paris, France
    Value Health 6:S10-9. 2003
  5. ncbi request reprint Effect of HAART on health status and hospital costs of severe HIV-infected patients: a modeling approach
    C Le Pen
    , Dauphine University, Paris, France
    HIV Clin Trials 2:136-45. 2001
  6. ncbi request reprint Cost-minimization study comparing Simulect vs. Thymoglobulin in renal transplant induction
    H Lilliu
    CLP Santé, Paris, France
    Clin Transplant 18:247-53. 2004
  7. ncbi request reprint The long-term effectiveness of preventive strategies for osteoporosis in postmenopausal women: a modeling approach
    C Le Pen
    University Paris Dauphine, Paris, France
    Osteoporos Int 11:524-32. 2000
  8. doi request reprint Hospital reimbursement price cap for cancer drugs: the French experience in controlling hospital drug expenditures
    A Degrassat-Théas
    Dauphine University, Paris, France
    Pharmacoeconomics 30:565-73. 2012
  9. ncbi request reprint Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France
    C Baudouin
    National Hospital Center of Ophthalmology of Quinze Vingts, Paris, France
    Eur J Ophthalmol 13:S53-60. 2003
  10. ncbi request reprint A comparison of radiopharmaceutical agents used for the diagnosis of pulmonary embolism
    N Rizzo-Padoin
    Department of Pharmacy, Lariboisiere Hospital, Paris, France
    Nucl Med Commun 22:375-81. 2001

Collaborators

Detail Information

Publications19

  1. ncbi request reprint The burden cost of French patients suffering from irritable bowel syndrome
    C Le Pen
    Université Paris Dauphine and CLP Santé, Paris, France
    Scand J Gastroenterol 39:336-43. 2004
    ..The impact of irritable bowel syndrome (IBS) on health-care resource use in France is evaluated, and explanatory variables determined...
  2. ncbi request reprint Choice of GPIIb/IIIa antagonist in percutaneous coronary intervention: how should economic criteria be factored in?
    Claude Le Pen
    CLP Santé, 9 11 rue du Mont Aigoual, 75015 Paris, France
    Pharm World Sci 27:83-91. 2005
    ..In France, as in many countries, their acquisition costs strongly differ. The objective of this study was to analyze how economic criteria-beyond the acquisition cost-should be factored in, when choosing a GPIIb/IIIa antagonist...
  3. ncbi request reprint [A cost-effectiveness analysis of changes in therapeutic strategies in the treatment of HIV since 1996]
    C Le Pen
    Université de Paris Dauphine, France
    Therapie 57:27-33. 2002
    ..0001) balanced by savings in other drugs expenses (-62%; p = 0.0560) and in hospitalizations (-25%; NS). Overall, CAS patients presented a 15% (NS) lower medical cost than CONTROL patients...
  4. ncbi request reprint The drug budget silo mentality: the French case
    Claude Le Pen
    University of Paris Dauphine, Paris, France
    Value Health 6:S10-9. 2003
    ....
  5. ncbi request reprint Effect of HAART on health status and hospital costs of severe HIV-infected patients: a modeling approach
    C Le Pen
    , Dauphine University, Paris, France
    HIV Clin Trials 2:136-45. 2001
    ..Important savings in hospital charges can compensate for the extra cost associated with the initiation of HAART...
  6. ncbi request reprint Cost-minimization study comparing Simulect vs. Thymoglobulin in renal transplant induction
    H Lilliu
    CLP Santé, Paris, France
    Clin Transplant 18:247-53. 2004
    ..Based on the data of clinical trial CHI-F-02 comparing the efficacy and safety of basiliximab (Simulect) vs. anti-thymocyte globulin (Thymoglobulin) in renal transplant induction, we carried out an economic evaluation...
  7. ncbi request reprint The long-term effectiveness of preventive strategies for osteoporosis in postmenopausal women: a modeling approach
    C Le Pen
    University Paris Dauphine, Paris, France
    Osteoporos Int 11:524-32. 2000
    ..5-2.1% decrease in all fractures. The combined strategies, S5 and S6, produce intermediate results: a 12.9-13.5% reduction in the number of all fractures and a 17.5-17.9% reduction in hip fractures...
  8. doi request reprint Hospital reimbursement price cap for cancer drugs: the French experience in controlling hospital drug expenditures
    A Degrassat-Théas
    Dauphine University, Paris, France
    Pharmacoeconomics 30:565-73. 2012
    ....
  9. ncbi request reprint Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France
    C Baudouin
    National Hospital Center of Ophthalmology of Quinze Vingts, Paris, France
    Eur J Ophthalmol 13:S53-60. 2003
    ..To analyze quantitative changes in glaucoma treatment strategies between 1997 and 2000 in France...
  10. ncbi request reprint A comparison of radiopharmaceutical agents used for the diagnosis of pulmonary embolism
    N Rizzo-Padoin
    Department of Pharmacy, Lariboisiere Hospital, Paris, France
    Nucl Med Commun 22:375-81. 2001
    ..66 (6 patients.day-1) to $US 266.47 (2 patients.day-1). This study shows that Kryptoscan appears to be preferable for ventilation scintigraphy whenever at least four patients are examined daily...
  11. ncbi request reprint Diagnosis related group costs in a regulated environment. A note about their economic interpretation
    C Le Pen
    Université Paris Dauphine et CLP Santé, Paris, France
    Pharmacoeconomics 17:115-20. 2000
    ..Therefore, the results of pharmacoeconomic studies should be considered and discussed in line with the national financing system of the hospitals involved...
  12. ncbi request reprint Health care reform in France--the birth of state-led managed care
    Victor G Rodwin
    Wagner School, New York University, and the World Cities Project, International Longevity Center USA, New York, USA
    N Engl J Med 351:2259-62. 2004
  13. ncbi request reprint [Cost-effectiveness analysis of capecitabine in combination with docetaxel in comparison to docetaxel monotherapy in advanced or metastatic breast cancer in France]
    Gaël Priol
    Aremis Consultants, 10, rue Beffroy, 92200 Neuilly sur Seine
    Bull Cancer 92:809-16. 2005
    ..A combined treatment associating capecitabine and docetaxel proves to be a cost-effectiveness strategy compared with the use of docetaxel alone, in the treatment of locally advanced or metastatic breast cancer in France...
  14. ncbi request reprint Financial cost of osteoarthritis in France. The "COART" France study
    Claude Le Pen
    Aremis Consultants, 10, rue Beffroy, 92200 Neuilly sur Seine, France
    Joint Bone Spine 72:567-70. 2005
    ..6 million with symptoms. The objective of the COART France study is to evaluate the cost of osteoarthritis in France from the societal point of view and to compare the results to those obtained in 1993 using the same methodology...
  15. ncbi request reprint Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL)
    Michel Amouretti
    Service de Gastroenterologie, Hopital du Haut leveque, CHU de Bordeaux, Pessac
    Gastroenterol Clin Biol 30:241-6. 2006
    ..To assess the impact of irritable bowel syndrome (IBS) on patient-reported health-related quality of life (HRQOL)...
  16. ncbi request reprint Medicoeconomic evaluation of hyaluronic acid for knee osteoarthritis in everyday practice: the MESSAGE study
    Bernard Mazieres
    Rheumatology Department, Rangueil Teaching Hospital, Toulouse, France
    Joint Bone Spine 74:453-60. 2007
    ..Our secondary objective was to evaluate treatment benefits in terms of pain, function, and quality of life...
  17. ncbi request reprint The burden of age-related macular degeneration: results of a cohort study in two French referral centres
    Julia Bonastre
    CLP Santé, Paris, France
    Pharmacoeconomics 21:181-90. 2003
    ..To describe the economic impact of age-related macular degeneration (AMD) and to assess its medical and non-medical costs...
  18. ncbi request reprint Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria
    Gilles Bommelaer
    Service d Hepato Gastroenterologie, hôpital de l Hôtel dieu, Clermont Ferrand
    Gastroenterol Clin Biol 28:554-61. 2004
    ....
  19. ncbi request reprint Cost-minimisation study of dorzolamide versus brinzolamide in the treatment of ocular hypertension and primary open-angle glaucoma: in four European countries
    Jean Francois Rouland
    Hopital Huriez, Service d Ophtalmologie, Lille Cedex, France
    Pharmacoeconomics 21:201-13. 2003
    ....